21h
Stocktwits on MSNMilestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s PositiveShares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and ...
Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...
HC Wainwright reiterated their buy rating on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research ...
Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...
Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others ...
In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...
Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.
Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.
Nuvectis Pharma, Inc.’s NVCT share price has dipped by 11.52%, which has investors questioning if this is right time to buy.
Indian auto and pharma stocks fell on Friday amid fears of a 25% U.S. tariff on auto imports. The Nifty Auto and Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results